In this issue:
- Adjunct therapeutic vaccine after TB treatment
- TB and COVID-19 co-infection
- Indoor air pollution and TB susceptibility in urban children
- Effect of quitting smoking during TB treatment
- Molecular detection of airborne M. tuberculosis in high schools
- All-oral 6-month regimen for MDR TB
- Predicting anti-TB treatment duration using 22-gene transcriptomics
- Bedaquiline resistance in rifampicin-resistant TB
- Meropenem + clavulanate (±rifampicin) for TB
- Adjunctive host-directed therapies for pulmonary TB
- Impact of time to treatment of nontuberculous mycobacterial pulmonary disease
- ALIS for M. avium complex lung disease
- Impact of emphysema in M. avium complex pulmonary disease
- Anxiety and depression in nontuberculous mycobacterial pulmonary disease
Please login below to download this issue (PDF)